-
In Vitro Models for Early Drug DiscoveryCytotoxicity, Apoptosis signalling pathways, Angiogenesis and Metastasis Assays, Inflammatory bowel disease (IBD)/CROHN’S, Drug-Induced Liver Injury (DILI), NAFLD & NASH, Alzheimer’s and Parkinson’s Disease -
Discovery Solutions to Biotech/Biopharma CompaniesSmall Molecules, Large Molecules, Recombinant DNA Technology, Monoclonal Antibodies, Cell permeability assays, CYP Induction/Inhibition, Bioactivity & Potency Testing -
3D Spheroid Model Based Toxicology and Safety StudiesHepatotoxicity & Drug-induced Liver Injury (DILI), Genotoxicity, Mitochondrial Toxicity, Cardiotoxicity, Neurotoxicity, 3D models -
Cell Line Engineering ServicesHost Cell Line Development, STR profile testing, Cell Surface Marker Validation Services, Cell Immortalization Services, Epigenetic Induction, NGS Sequencing -
Stem Cell Based Research ServicesIsolation and Characterization, Flow cytometry, 3D organoids, Osteogenesis, CD Markers, Mesenchymal Stem Cells, iPSCs, Neuronal Differentiation, Trans-Differentiation studies, Exosomes -
In Vitro ADME/DMPK ServicesIn Vitro Metabolism, Drug-Drug Interactions, Permeability Assays, CaCo2, PAMPA, BBB Models, Cytochrome P450 Induction/Inhibition, Plasma Protein Binding Assays
A Preclinical Contract Research Organization (CRO)
Located in Bangalore, India, Stellixir Biotech Pvt. Ltd is a niche preclinical R&D service provider. Vested in the hands of remarkably skilled professionals and top-notch research scientists, Stellixir integrates quality and innovation to provide rapid and reliable solutions in distinct specialties, under the umbrella of in vitro preclinical toxicity studies and stem cell research. Our core capacities include anti-cancer cell-based drug screening, predictive toxicology, biomarker analysis, 3D spheroid culture, and stem cell assay development and screening.
With its custom-built, state-of-the-art facilities, including Class 10,000(ISO 7) and Class 100,000(ISO 8) cleanroom areas, Stellixir places heavy emphasis on adherence to the established regulatory standards, and henceforth delivering high quality services. By constantly providing consistent, reliable and accelerated solutions, we envision becoming an outstanding service partner to our clients of the pharmas, biotechs and the academics.
